Metabolic comorbidities and the association with risks of recurrent metastatic disease in breast cancer survivors.
Sumadi Lukman AnwarRoby CahyonoDayat PrabowoWidya Surya AvantiLina ChoridahEry Kus DwianingsihWirsma Arif HarahapTeguh AryandonoPublished in: BMC cancer (2021)
Metabolic comorbidities were frequently found in breast cancer patients and were associated with higher risks to develop recurrent metastatic disease, particularly in post-menopausal women. Subsequent larger studies are needed to better understand the association of metabolic comorbidities with patients' quality of life and prognosis, and to explore the potential combination of clinical intervention and lifestyle modification in breast cancer survivors to treat as well as reduce their impact.
Keyphrases
- end stage renal disease
- human health
- squamous cell carcinoma
- small cell lung cancer
- randomized controlled trial
- ejection fraction
- chronic kidney disease
- newly diagnosed
- metabolic syndrome
- polycystic ovary syndrome
- risk assessment
- cardiovascular disease
- peritoneal dialysis
- physical activity
- prognostic factors
- type diabetes
- adipose tissue
- pregnant women
- climate change
- insulin resistance
- case control